Table I.
Characteristic | Patient 1 | Patient 2 |
---|---|---|
Age at | ||
Diagnosis | 2 months | 11 years |
HCT | 9 months | 16 years |
IPEX features | ||
Immune dysregulation | Eosinophilia (1000–2000/mm3) | Eosinophilia (>2000/mm3) |
Hyper-IgE (183 IU/mL) | Hyper-IgE (842 IU/mL) | |
Anticardiolipin antibodies (DVT) | Hypogammaglobulinemia (204 mg/dL) | |
Hemolytic anemia | Anemia | |
Infections | Infections | |
Membranous nephropathy | ||
Polyendocrinopathy | Diabetes | Diabetes |
Hypothyroidism | ||
Growth Hormone Deficiency | ||
Enteropathy | Diarrhea | Diarrhea |
Failure to thrive | Failure to thrive | |
Other | Steroid dependent interstitial lung disease | |
Osteopenia | ||
Seizure disorder | ||
FOXP3 gene | ||
Mutation* | c.210_210+1GG>AC | c.816+7G>C |
Mutation significance | Abnormal mRNA splicing | Abnormal mRNA splicing |
Protein expression | Absent | Reduced |
Infections | ||
Bacterial | Skin abscesses | Recurrent pneumonias |
Staphylococcus aureus | ||
MRSA | ||
Brain abscess | ||
Sepsis | ||
Group A streptococcus | ||
Enterococcus Faecalis | ||
Coagulase negative | ||
Staphylococcus | ||
Fungal | Fungemia | Skin abscesses |
Candida albicans | Alternaria | |
Viral | Viremia | Viremia |
Cytomegalovirus | Cytomegalovirus | |
EBV | ||
EBV-lymphoproliferative disorders of lungs and intestinal tract |
Mutation nomenclature per den Dunnan and Antonarakis.(25)
EBV, Epstein-Barr virus; HCT, hematopoietic cell transplantation; MRSA, methicillin-resistant Staphylococcus aureus